Latest Pfizer Stories

2014-05-02 23:08:45

One of the world's leading biopharmaceutical companies, Pfizer, has selected Sepha’s non-destructive inspection device for blister packs, called Visionscan, as their preferred global standard for blister packaging inspection. Visionscan is the world’s first, non-destructive, tool-less inspection device for blister packs and was developed by the Northern Ireland based packaging engineering firm Sepha Ltd. Visionscan will help Pfizer reduce inspection costs and drive up accuracy...

2014-05-02 08:26:09

NEW YORK, May 2, 2014 /PRNewswire/ -- Porter Novelli has named Dr. Doug Elwood senior vice president and medical advisor of Porter Novelli's Health & Wellness group in New York and Suzannah Palinkas senior vice president of its Health & Wellness group in Washington D.C. Both are new positions reporting respectively to Paul George, global director of health, and Rosemary McGillan, executive vice president of health and social marketing. "Porter Novelli's Health and Wellness...

2014-05-02 08:25:57

NORTHBROOK, Ill., May 2, 2014 /PRNewswire/ -- Astellas announces the promotion of Bernhardt Zeiher, M.D. ("Bernie") to the position of executive vice president, Global Development and the appointment of Jeannette A. Barrett, PhD, to the position of vice president and head of Medical Excellence, Global Medical Affairs. In his new role, Dr. Zeiher will assume line responsibility for Global Development Operations and Global Clinical Pharmacology and Exploratory Development (GCPED), in...

2014-05-02 00:21:47

SOUTH SAN FRANCISCO, Calif., May 2, 2014 /PRNewswire/ -- Second Genome announced today that it has entered into an agreement with Pfizer Inc. to conduct extensive microbiome research in a large observational study aimed at gaining new insights into obesity and metabolic disease. The goal of the study is to evaluate numerous clinical factors and the microbiome in a select cohort of approximately 900 individuals with varying metabolic phenotypes, in order to better understand the...

2014-05-01 20:24:02

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dfhjv9/global_orphan) have announced the addition of the "Global Orphan Drugs Market 2014-2018" [http://www.researchandmarkets.com/research/dfhjv9/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018....

2014-05-01 16:32:50

CUPERTINO, Calif., May 1, 2014 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) announced today financial results for the first quarter of 2014. Total revenues were $6.3 million and net loss was $3.6 million for the three months ended March 31, 2014 as compared to total revenues of $4.2 million and net loss of $5.2 million for the three months ended March 31, 2013. At March 31, 2014, we had cash and investments of $21.8 million, compared to cash and investments of $24.4 million at December...

2014-05-01 04:22:33

Experts Intrigued by Clinical Research Behind Oral Growth Hormone Booster SeroVital®-hgh SAN DIEGO, May 1, 2014 /PRNewswire/ -- It seems everybody is intrigued by the legendary "Fountain of Youth"... even scientists. That's why experts at the Experimental Biology conference that ended yesterday in San Diego lined up at an exhibit discussing the "Wonder Hormone" everyone's been talking about... human growth hormone (hGH). Why is hGH such big news? Because for years, researchers have...

2014-04-30 23:05:48

The Charleston-based law firm continues to investigate claims of women who developed Type II diabetes after taking the cholesterol-lowering drug Lipitor as 56 cases are centralized into multidistrict litigation in South Carolina. CHARLESTON, W.Va. (PRWEB) April 30, 2014 The Bell Law Firm’s Charleston Lipitor attorneys are currently investigating injury claims related to the development of Type II diabetes in women who took Lipitor in light of the recent consolidation of 56 similar cases...

2014-04-30 11:51:15

Found to be 'safe and well tolerated' in randomized clinical trial A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarction. This effect,say the investigators, was consistent across all study sub-groups, but was "particularly obvious in patients undergoing reperfusion within six hours of symptom onset". Eplerenone, a mineralocorticoid receptor...

2014-04-30 08:32:52

TORONTO, April 30, 2014 /CNW/ - April 30th is National Honesty Day, and a new survey of Canadians shows that it's time smokers were honest with themselves about how their smoking is impacting all aspects of their relationships. SOURCE Pfizer Canada Inc.

Latest Pfizer Reference Libraries

Generalized Anxiety Disorder
2013-07-25 15:07:54

Generalized Anxiety Disorder (GAD) is an anxiety disorder with worry about normal, everyday situations such as finance, health and wellbeing in relationships (personal and work related) all lasting longer than six months. Symptoms The symptoms of GAD can include but are not limited to difficulty swallowing, rashes, shortness of breath, fidgeting, headaches, tension, nausea, etc. In order for GAD to be ruled as present, the symptoms and feelings must be experiences for at least six...

2011-04-15 13:50:01

Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...

More Articles (2 articles) »
Word of the Day
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.